ZSTK474

DRUG2 trials

Sponsors

Zenyaku Kogyo Co., Ltd.

Conditions

Neoplasms

Phase 1

A Safety Study of Oral ZSTK474 in Patients With Cancer

CompletedNCT01280487

Zenyaku Kogyo Co., Ltd.Neoplasms

Start: 2011-01-31End: 2014-01-31Updated: 2015-01-16

A Study of ZSTK474 in Japanese Patients With Advanced Solid Malignancies

CompletedNCT01682473

Zenyaku Kogyo Co., Ltd.Neoplasms

Start: 2012-09-20End: 2015-04-20Updated: 2017-07-06